RPRXRoyalty Pharma plc

NASDAQ · Healthcare · Large Cap · Mkt cap $19.3B · Vol 9.90M

$36.67

▲ +0.03% today

Fetching live price…

God's Eye forensics

Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.

Piotroski F-Score

5/5

5

5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).

Altman Z-Score

Insufficient data

—

Needs total assets, operating profit and debt — not published for this listing yet.

Beneish (earnings quality)

Insufficient data

—

The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.

Scores are free. The criteria-by-criteria breakdown — exactly which checks this company failed — is part of DeepScreen Pro.

Fundamental breakdown — raw ratios are free · fetching live data — showing modeled estimates for now

P/E Ratio (TTM)

Modeled

22.2x

Fairly priced

Contextual insight — DeepScreen Pro

PEG Ratio

Modeled

1.98

Overvalued vs. growth

Contextual insight — DeepScreen Pro

P/S Ratio

Modeled

2.71x

Moderate

Contextual insight — DeepScreen Pro

P/B Ratio

Modeled

7.68x

Typical for the sector

Contextual insight — DeepScreen Pro

EV/Revenue

Modeled

2.47x

Low for an asset-light business

Contextual insight — DeepScreen Pro

EV/EBITDA

Modeled

9.5x

Low for asset-light

Contextual insight — DeepScreen Pro

ROE

Modeled

34.6%

Excellent shareholder returns

Contextual insight — DeepScreen Pro

ROA

Modeled

25.3%

Strong for asset-light

Contextual insight — DeepScreen Pro

ROCE

Modeled

30.9%

High-quality compounder

Contextual insight — DeepScreen Pro

Debt / Equity

Modeled

0.02x

Conservative balance sheet

Contextual insight — DeepScreen Pro

LT Debt / Equity

Modeled

0.02x

Very low structural debt

Contextual insight — DeepScreen Pro

Payout Ratio

Modeled

47%

Ideal balance — sustainable with room to reinvest

Contextual insight — DeepScreen Pro

Operating Leverage

Modeled

0.98x

Low fixed-cost gearing

Contextual insight — DeepScreen Pro

Company financials

EPS (TTM): $1.65
Revenue (TTM): $7.1B
Net margin: 12.2%
EBITDA margin: 26%
Earnings growth: 11.2%
Dividend yield: 2.12%
Payout ratio: 47%
Debt / equity: 0.02x

Live data hasn't loaded yet — figures shown are DeepScreen's modeled estimates.

RPRX live news

LIVE

Loading live headlines…